Skip to search formSkip to main contentSkip to account menu

omega-3 ethyl ester 90

Known as: P-OM3 adjunct 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The metabolic syndrome includes both dyslipidemia and impaired vascular function. Because extended-release niacin (ERN) and… 
Highly Cited
2010
Highly Cited
2010
OBJECTIVE To evaluate the effects of prescription omega-3-acid ethyl esters on non-high-density lipoprotein cholesterol (HDL-C… 
2010
2010
Abstract Objective: Assess the long-term efficacy and safety of prescription omega-3-acid ethyl esters (P-OM3) coadministered… 
Highly Cited
2008
Highly Cited
2008
Introduction: Omega‐3 fatty acids (n‐3 FA) lower triglycerides and risk of heart attacks. Accordingly, patients at risk are often… 
Review
2008
Review
2008
Background: Moderate hypertriglyceridemia is fairly common, and elevated triglycerides are a risk factor for coronary heart… 
2006
2006
The coadministration of prescription omega‐3‐acid ethyl esters (P‐OM3) with a statin may present a treatment option for patients…